News

Filter

Current filters:

None

7890 to 7899 of 96176 results

US FDA delays Eisai's Dacogen for AML; accepts perampanel NDA

08-03-2012

The US Food and Drug Administration has issued a Complete Response Letter to Japanese drug major Eisai…

Astex PharmaceuticalsDacogenEisaiNeurologicalNorth AmericaOncologyperampanelPharmaceuticalRegulation

Mersana inks ADC deal with Endo Pharma

08-03-2012

Privately-held Mersana Therapeutics has joined the antibody-drug conjugate space, announcing its first…

BiotechnologyEndo PharmaceuticalsLicensingMersanaOncology

Gilead's Quad non-inferior to Atripla for HIV; Truvada objections

08-03-2012

US biotech firm Gilead Sciences (Nasdaq: GILD) yesterday announced full Phase III clinical trial results…

Anti-viralsAtriplaBiotechnologyGilead SciencesNorth AmericaQuadRegulationResearchTruvada

Most admired pharma companies in Japan, by IAL

07-03-2012

Since 1999 International Alliances Limited (IAL), headed by P Reed Maurer, has conducted an annual survey…

Asia-PacificManagementMarkets & MarketingPharmaceutical

Outlook for pharmaceuticals in Western Europe

07-03-2012

Market growth in the mature markets of Western Europe is assured over the coming years by the health…

EuropeMarkets & MarketingPharmaceutical

Domain partners with RusNano on drug production in Russia

07-03-2012

Russian state nanotechnology corporation RusNano and Domain Associates, a US venture fund, are to invest…

Domain AssociatesEuropeFinancialPharmaceuticalRusNano

New pharma plant in Tanzania to produce ARVs

07-03-2012

Tanzania will start the first domestic commercial production of antiretroviral (ARV) drugs in the next…

Anti-viralsGenericsMarkets & MarketingRest of the World

Forest Labs and Pierre Fabre's levomilnacipran positive in Ph III

07-03-2012

US drugmaker Forest Laboratories (NYSE: FRX) and France-based Pierre Fabre have announced positive top-line…

Forest LaboratorieslevomilnacipranNeurologicalPharmaceuticalPierre FabreResearch

Merck KGaA 4th-qtr profits triple, but miss expectations

07-03-2012

German drug major Merck KGaA (MRK: DE) posted a massive improvement in fourth-quarter 2011 net profit,…

FinancialMerck KGaAPharmaceutical

7890 to 7899 of 96176 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top